跳到正文
MHRA 药品召回与缺陷通报·精选AI 评分80

MHRA 对 Beckton Dickson UK Ltd 的 ChloraPrep 1mL 涂抹器发布二级药品召回 EL(26)A/34

Class 2 Medicines Recall: Beckton Dickson UK Ltd, ChloraPrep 1mL applicator, EL(26)A/34

AI 导读

MHRA 发布二级药品召回通报,Beckton Dickson UK Ltd 召回 ChloraPrep 1mL 涂抹器,原因为包装工序可能存在无菌性破坏。召回涵盖有效期截至 2029 年 5 月(含)的所有批次,有效期在其后的批次不受影响,通报称因每批受影响数量未知而作为预防性措施。

推荐理由

通报以有效期截至 2029 年 5 月为界划分受影响批次,并列出了医疗机构停用、隔离和退回的具体操作。

正文 · 原文

Contents

  1. DMRC reference number
  2. Marketing Authorisation Holder
  3. Medicine Details
    1. ChloraPrep 1mL Applicator
  4. Affected Lot Batch Numbers
  5. Background
  6. Advice for Healthcare Professionals
  7. Advice for Patients
  8. Additional information
  9. Download document

DMRC reference number

DMRC - 40102707

Marketing Authorisation Holder

Beckton Dickson UK Ltd

Medicine Details

ChloraPrep 1mL Applicator

PL: 05920/0002

Active Ingredient: Chlorhexidine gluconate 2%w/v and isopropyl alcohol 70% v/v

SNOMED code: 40818111000001106

GTIN: 20885403491761

Affected Lot Batch Numbers

Batch No. Expiry Date Pack Size First Distributed
All lots with an expiry date up to and including 05/2029* All lots with an expiry date up to and including 05/2029* ChloraPrep 1mL Applicator: 60 applicators 25/06/2025

*For a full list of impacted batches, see Annex 1

Background

Becton Dickinson UK Ltd are recalling batches of ChloraPrep 2% w/v / 70% v/v cutaneous solution 1mL applicators due to a potential breach of sterility in the packaging process. The recall applies to all batches with an expiry date up to and including 05/2029. Batches with an expiry date after 05/2029 are not impacted.

This defect could increase the risk of the applicator device being contaminated with pathogens, which could lead to increased infection rates for the patients. The number of impacted units in each batch is unknown, therefore the batches included in Annex 1 are being recalled as a precautionary measure.

This recall is specific to the lots in included in Annex 1.

Advice for Healthcare Professionals:

Stop supplying the affected batches. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Advice for Patients:

No further action is required by patients as this product is used by healthcare professionals and they will have taken the action to remove this product from use.

The recall is a precautionary measure to mitigate any additional risk of infection.

Patients who experience adverse reactions or have any questions about their medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.

Additional information:

For all medical information enquiries and information on this product, please email safetyinformation@bd.com, or telephone 08000437546.

For stock control enquiries please email info@insightbio.com, or telephone 01707351330.

Recipients of this Medicines Recall should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.

Yours faithfully

Defective Medicines Report Centre

10 South Colonnade

Canary Wharf

London

E14 4PU

Telephone +44 (0)20 3080 6574

DMRC@mhra.gov.uk

Download document

Class 2 Medicines Recall: Beckton Dickson UK Ltd, ChloraPrep 1mL applicator, EL(26)A/34

来源:MHRA 药品召回与缺陷通报 · gov.uk